Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal assessment based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines with the Accuryn ...

Objective To systematically identify and describe self-management interventions for adult patients with chronic kidney disease (CKD ... clinical practice guidelines, theses and opinion-driven reports ...

The inaugural ADPKD guideline from KDIGO provides updated recommendations on therapies to slow disease progression, including the use of tolvaptan. In January 2025, Kidney Disease: Improving ...

SINGAPORE: While much of a child’s screen time happens at home, experts say new guidelines on screen use in schools can significantly shape children's habits. Dr Ong Say How from the Institute ...

(11) Booster doses of PPSV23 are recommended five years after the initial PPSV23 dose, particularly for patients aged 19-64 years, as per the Kidney Disease: Improving Global Outcomes (KDIGO) ...

(Photo: CNA/Lim Li Ting) New: You can now listen to articles. SINGAPORE: Guidelines on screen use will be introduced in schools, including preschools, as part of a new national strategy launched ...